PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378634
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378634
Global chemotherapy devices market is estimated to be valued at US$ 17 Bn in 2023, and is expected to exhibit a CAGR of 7.7% during the forecast period (2023-2030).
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 17 Bn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: | 7.70% | 2030 Value Projection: | US$ 28.5 Bn |
Chemotherapy devices are medical devices that are utilized for the administration of chemotherapy drug to cancer patients undergoing treatment. Some of the widely used chemotherapy devices include chemotherapy disposables & accessories and chemotherapy infusion pumps. Chemotherapy involves the use of drugs to destroy cancer cells, and is used for cancer treatment. A wide range of portable infusion pumps, disposable sets and needles, implantable ports, and pumps are used for effective delivery of chemotherapeutic agents. Increasing adoption of advanced chemotherapy devices such as continuous infusion pumps and wearable pumps that enables ambulatory chemotherapy are expected to drive the market growth. Rising demand for home healthcare and point-of-care services can boost adoption of self-administered chemotherapy devices in recent times. However, the high costs associated with chemotherapy devices may hamper the market growth over the forecast period.
Global chemotherapy devices market growth is driven by rising prevalence of cancer and increasing reliance on chemotherapy for its treatment. In June 2021, according to the World Health Organization's (WHO) estimates, cancer burden hhas doubled from the year 2000 to 2018, increasing to 18.1 Mn new cases and 9.6 Mn cancer-related deaths in 2018. This rapidly increasing cancer patient pool seek chemotherapy treatment, and this boostsdemand for chemotherapy devices. The availability of advanced chemotherapy devices with benefits such as precision in drug administration, portability enabling home healthcare, and wireless connectivity for monitoring patients remotely promotes adoption of chemotherapy treatment. However, the high costs associated with chemotherapy drugs and devices remain a major challenge, particularly in price-sensitive developing economies. Moreover, the risks and side-effects of chemotherapy continue to restrain the reliant on this treatment modality to some extent. Ongoing advancements in chemotherapy devices aimed at improving safety, efficiency, and the patient's comfort represents new opportunities for market players.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chemotherapy devices market
Chemotherapy Devices Market Detailed Segmentation: